Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.06 AUD | -0.98% | -4.87% | -17.40% |
May. 24 | Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack | MT |
May. 10 | Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.40% | 279M | |
+16.31% | 42.32B | |
+16.11% | 21.29B | |
+19.33% | 15.29B | |
+18.71% | 14.36B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-12.40% | 6.58B | |
-8.87% | 5.73B | |
+14.28% | 5.51B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024